As S100A8 was predominantly highly expressed on the surface of B cells in patients with active SLE (Fig. 2), S100A8 (monomer or homodimer) is considered to be associated with B cell activation and is an igniter of innate immune activation triggered by BCR stimulation. Here, BCR is linked to systemic lupus erythematosus.